Terms: = Colorectal cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Treatment
17 results:
1. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
[TBL] [Abstract] [Full Text] [Related]
2. Circ-malat1 accelerates cell proliferation and epithelial mesenchymal transformation of colorectal cancer through regulating miR-506-3p/KAT6B axis.
Yang FS; Gong SX; Qiu DD
Kaohsiung J Med Sci; 2023 Sep; 39(9):862-872. PubMed ID: 37272875
[TBL] [Abstract] [Full Text] [Related]
3. COPA A-to-I RNA editing hijacks endoplasmic reticulum stress to promote metastasis in colorectal cancer.
Wang SY; Zhang LJ; Chen GJ; Ni QQ; Huang Y; Zhang D; Han FY; He WF; He LL; Ding YQ; Jiao HL; Ye YP
Cancer Lett; 2023 Jan; 553():215995. PubMed ID: 36336148
[TBL] [Abstract] [Full Text] [Related]
4. malat1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.
Matuszyk J
Mol Med; 2022 Aug; 28(1):89. PubMed ID: 35922756
[TBL] [Abstract] [Full Text] [Related]
5. Early-stage colon cancer with high malat1 expression is associated with the 5-Fluorouracil resistance and future metastasis.
Ak Aksoy S; Tunca B; Erçelik M; Tezcan G; Ozturk E; Cecener G; Ugras N; Yilmazlar T; Yerci O
Mol Biol Rep; 2022 Dec; 49(12):11243-11253. PubMed ID: 35794508
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA metastasis-related lung adenocarcinoma transcript 1 (malat1) forms a negative feedback loop with long non-coding RNA colorectal neoplasia differentially expressed (CRNDE) in sepsis to regulate lung cell apoptosis.
Yue C; He M; Teng Y; Bian X
Bioengineered; 2022 Apr; 13(4):8201-8207. PubMed ID: 35300579
[TBL] [Abstract] [Full Text] [Related]
7. Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer.
Kim M; Min YK; Jang J; Park H; Lee S; Lee CH
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253638
[TBL] [Abstract] [Full Text] [Related]
8. malat1: A Promising Therapeutic Target for the treatment of Metastatic colorectal cancer.
Uthman YA; Ibrahim KG; Abubakar B; Bello MB; Malami I; Imam MU; Qusty N; Cruz-Martins N; Batiha GE; Abubakar MB
Biochem Pharmacol; 2021 Aug; 190():114657. PubMed ID: 34144008
[TBL] [Abstract] [Full Text] [Related]
9. Long Noncoding RNA malat1 Promotes colorectal cancer Progression by Acting as a ceRNA of miR-508-5p to Regulate RAB14 Expression.
Zhang C; Yao K; Zhang J; Wang C; Wang C; Qin C
Biomed Res Int; 2020; 2020():4157606. PubMed ID: 33344634
[TBL] [Abstract] [Full Text] [Related]
10. Aberrant expression of lncRNA malat1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer.
Lampropoulou DI; Aravantinos G; Katifelis H; Lazaris F; Laschos K; Theodosopoulos T; Papadimitriou C; Gazouli M
Cancer Biomark; 2019; 25(2):213-221. PubMed ID: 31045514
[TBL] [Abstract] [Full Text] [Related]
12. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA malat1 in colorectal cancer cells.
Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
[TBL] [Abstract] [Full Text] [Related]
13. malat1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in colorectal cancer Patients and Promotes Chemoresistance through EZH2.
Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
[TBL] [Abstract] [Full Text] [Related]
14. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract] [Full Text] [Related]
15. Differentially expressed long non-coding RNAs and the prognostic potential in colorectal cancer.
Li Q; Dai Y; Wang F; Hou S
Neoplasma; 2016; 63(6):977-983. PubMed ID: 27596298
[TBL] [Abstract] [Full Text] [Related]
16. Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 cancer Cell Line.
Fűri I; Kalmár A; Wichmann B; Spisák S; Schöller A; Barták B; Tulassay Z; Molnár B
PLoS One; 2015; 10(7):e0131699. PubMed ID: 26133168
[TBL] [Abstract] [Full Text] [Related]
17. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via malat1 mediated Wnt/β-catenin signal pathway.
Ji Q; Liu X; Fu X; Zhang L; Sui H; Zhou L; Sun J; Cai J; Qin J; Ren J; Li Q
PLoS One; 2013; 8(11):e78700. PubMed ID: 24244343
[TBL] [Abstract] [Full Text] [Related]
